Shang Hai Zheng Quan Bao·2025-08-26 21:20Core Points - The company has released its 2025 semi-annual report, which includes financial results and future development plans [1][2] - The board of directors confirmed the authenticity, accuracy, and completeness of the report, taking legal responsibility for its content [2] - The board meeting was held on August 25, 2025, with all nine directors participating and unanimously approving the semi-annual report [2] Financial Data - The semi-annual report contains key financial data, although specific figures are not detailed in the provided text [1] - The report has been reviewed by the company's audit committee before being submitted to the board for approval [2] Important Matters - The company has not reported any significant changes in its operating conditions during the reporting period [1] - A resolution was passed to approve a donation of 390,000 RMB by its subsidiary, Jiangxi Gannan Haixin Pharmaceutical Co., Ltd., to the Jiangxi Red Cross Foundation, which is not expected to significantly impact the company's financial performance [3]